Abivax stock skyrocketed in July after the company announced overwhelmingly positive topline results from its Phase 3 ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

ToolGen Inc. (KOSDAQ: 199800), a leading genome editing company based in Korea, announced today that it has entered into a strategic cross-license agreement with GenEditBio Limited ("GenEditBio"), a ...

Eli Lilly LLY secured a significant milestone on Friday when it became the first company in the healthcare space to reach $1 trillion in market value. With this breakthrough, Lilly is now the second ...

Verve has hired Amanda Lie as an agent on their talent team, Variety has learned exclusively. Lie joins Verve from M88, where she worked as a talent manager since December 2024. Prior to that, she was ...